Entries by oncotron

2024 a transformational year of progress: A note from the CEO

2024 has been a transformational year for Curve.  We kicked off the year with a significant  Series A financing, raising £40.5 million from a world class syndicate which includes our existing blue chip investors Advent Life Sciences and Epidarex Capital, alongside new investment from Pfizer Ventures, Columbus Venture Partners and British Patient Capital. The financing […]

London Life Sciences Week

London Life Sciences Week 17-21 November 2024 London, UK CEO Simon Kerry and Head of Business Development Cora Griffin attending

BIO-Europe 2024

BIO-Europe 2024 4-6 November 2024 Stockholm, Sweden CEO Simon Kerry and Head of Business Development Cora Griffin attending

Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer

Southampton, UK, 9 October 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the appointment of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer. This continues Curve’s strong momentum expanding its leadership team following the recent appointments of Andre Hoekema and Cora Griffin, joining as Chair of the Board and Head of Business Development respectively.

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the further strengthening of its leadership team with the appointments of Andre Hoekema as Chair of the Board and Cora Griffin as Head of Business Development.

Curve Therapeutics strengthens Leadership Team with appointment of experienced biotech executive Simon Jones

Accomplished CFO and COO with proven track record in the biotech and pharmaceutical industry Strengthens Curve’s Leadership Team following £40.5 million Series A financing Southampton, UK, 9 July 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the […]

Bio€quity Europe 2024

Bio€quity Europe 2024 12-14 May 2024 San Sebastián, Spain Simon Kerry, CEO, delivering presentation: 13 May, 15.00pm-15.10pm CEST, Room 9 Simon also participating in McKinsey panel: ‘Learnings on how to Rise above the Noise’, 11.30am-12.30pm CEST

BioTrinity 2024

BioTrinity 2024 23-25 April 2024 London, UK Simon Kerry, CEO, attended.